Venues

Don’t Miss Your Chance: ONS Congress® Late-Breaking Abstract Submissions are Due This Week Submit your abstract by 5 pm ET on January 13 for your chance to share an ePoster or oral abstract presentation to your peers in-person at ONS Congress.  Abstracts will be accepted in the following categories:  Clinical Practice  Advanced Practice  Leadership/Management/Education  Research  Quality Improvement  Industry-Supported  International   Use your voice to empower and motivate nurses from across the country to improve their practice. Submit an Abstract » Notifications will be sent in mid-February. If selected for presentation your materials will be due as early as March 10, 2022.   Learn more about submission guidelines and information on the call for late-breaking abstract submissions.   Interested in reviewing abstracts? Sign up to volunteer as an abstract reviewer. Reviewers are sought for all topic categories. The health and safety of ONS Congress attendees, exhibitors, and staff remains our top priority as we return to in-person events. We are making preparations to ensure the highest standards of safety, hygiene, cleanliness, and operational effectiveness for all participants of ONS Congress. Please visit n.ons.org/health-safety to learn more. The Oncology Nursing Society is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.  ONS is approved as a provider of continuing education by the California Board of Registered Nursing, Provider #2850.  The contact hours earned from this educational opportunity qualify for initial oncology nursing certification and renewal via ILNA.  Visit www.oncc.org for complete details on oncology nursing certification. To keep receiving emails from ONS, ask your email administrator to add emailer.realmagnet.com and realmagnet.com to your whitelist. Oncology Nursing Society   125 Enterprise Drive    Pittsburgh  PA   15275   USA  Toll-free phone: 866-257-4ONS (866-257-4667)

This February we are pleased to be heading back to San Francisco for the 2022 Genitourinary Cancers Symposium to host 2 programs with both onsite and virtual viewing options. As with our previous visits, these live programs will be designed to improve clinicians’ knowledge and assist them in becoming more effective by going “Beyond the Guidelines” for the clinical care of patients with an array of GU cancers.

We will kick off our 2-part series on Thursday evening, February 17th as we explore the management of prostate cancer. On the following evening, February 18th, we will focus on bladder cancer.

Our renowned faculty panel will review recently published research data and ongoing clinical trials, and they will discuss the results of a unique educational survey we created documenting 20 clinical investigator recommendations for a variety of challenging cases and questions. To make these programs even more relevant, clinicians in attendance will be able to use iPads® to complete surveys incorporating many of the same questions. Results from both cohorts will be juxtaposed and used to augment the panel discussions.

We can’t wait to get to San Francisco, and we hope that you will make plans to join us for one or both of these educational opportunities either in person or online.